These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 28358123)
1. Molecular Therapy for Degenerative Disc Disease: Clues from Secretome Analysis of the Notochordal Cell-Rich Nucleus Pulposus. Matta A; Karim MZ; Isenman DE; Erwin WM Sci Rep; 2017 Mar; 7():45623. PubMed ID: 28358123 [TBL] [Abstract][Full Text] [Related]
2. Notochordal cells protect nucleus pulposus cells from degradation and apoptosis: implications for the mechanisms of intervertebral disc degeneration. Erwin WM; Islam D; Inman RD; Fehlings MG; Tsui FW Arthritis Res Ther; 2011; 13(6):R215. PubMed ID: 22206702 [TBL] [Abstract][Full Text] [Related]
3. Notochordal Cell Matrix As a Therapeutic Agent for Intervertebral Disc Regeneration. de Vries S; Doeselaar MV; Meij B; Tryfonidou M; Ito K Tissue Eng Part A; 2019 Jun; 25(11-12):830-841. PubMed ID: 29739272 [TBL] [Abstract][Full Text] [Related]
4. Influence of rabbit notochordal cells on symptomatic intervertebral disc degeneration: anti-angiogenic capacity on human endothelial cell proliferation under hypoxia. Kwon WK; Moon HJ; Kwon TH; Park YK; Kim JH Osteoarthritis Cartilage; 2017 Oct; 25(10):1738-1746. PubMed ID: 28647468 [TBL] [Abstract][Full Text] [Related]
5. Co-culturing nucleus pulposus mesenchymal stem cells with notochordal cell-rich nucleus pulposus explants attenuates tumor necrosis factor-α-induced senescence. Li XC; Wang MS; Liu W; Zhong CF; Deng GB; Luo SJ; Huang CM Stem Cell Res Ther; 2018 Jun; 9(1):171. PubMed ID: 29941029 [TBL] [Abstract][Full Text] [Related]
6. CCN family member 2/connective tissue growth factor (CCN2/CTGF) is regulated by Wnt-β-catenin signaling in nucleus pulposus cells. Hiyama A; Morita K; Sakai D; Watanabe M Arthritis Res Ther; 2018 Sep; 20(1):217. PubMed ID: 30268161 [TBL] [Abstract][Full Text] [Related]
7. NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease. Matta A; Karim MZ; Gerami H; Jun P; Funabashi M; Kawchuk G; Goldstein A; Foltz W; Sussman M; Eek BC; Erwin WM Sci Rep; 2018 Nov; 8(1):16809. PubMed ID: 30429487 [TBL] [Abstract][Full Text] [Related]
8. Notochordal cell-derived conditioned medium protects human nucleus pulposus cells from stress-induced apoptosis. Mehrkens A; Matta A; Karim MZ; Kim S; Fehlings MG; Schaeren S; Mark Erwin W Spine J; 2017 Apr; 17(4):579-588. PubMed ID: 28089818 [TBL] [Abstract][Full Text] [Related]
9. Notochordal cell conditioned medium stimulates mesenchymal stem cell differentiation toward a young nucleus pulposus phenotype. Korecki CL; Taboas JM; Tuan RS; Iatridis JC Stem Cell Res Ther; 2010 Jun; 1(2):18. PubMed ID: 20565707 [TBL] [Abstract][Full Text] [Related]
10. Canonical Wnt signaling in the notochordal cell is upregulated in early intervertebral disk degeneration. Smolders LA; Meij BP; Riemers FM; Licht R; Wubbolts R; Heuvel D; Grinwis GC; Vernooij HC; Hazewinkel HA; Penning LC; Tryfonidou MA J Orthop Res; 2012 Jun; 30(6):950-7. PubMed ID: 22083942 [TBL] [Abstract][Full Text] [Related]
11. Bai XD; Li XC; Chen JH; Guo ZM; Hou LS; Wang DL; He Q; Ruan DK Tissue Eng Part A; 2017 Aug; 23(15-16):837-846. PubMed ID: 28145804 [TBL] [Abstract][Full Text] [Related]
14. Native nucleus pulposus tissue matrix promotes notochordal differentiation of human induced pluripotent stem cells with potential for treating intervertebral disc degeneration. Liu Y; Fu S; Rahaman MN; Mao JJ; Bal BS J Biomed Mater Res A; 2015 Mar; 103(3):1053-9. PubMed ID: 24889905 [TBL] [Abstract][Full Text] [Related]
15. Human iPSCs can be differentiated into notochordal cells that reduce intervertebral disc degeneration in a porcine model. Sheyn D; Ben-David S; Tawackoli W; Zhou Z; Salehi K; Bez M; De Mel S; Chan V; Roth J; Avalos P; Giaconi JC; Yameen H; Hazanov L; Seliktar D; Li D; Gazit D; Gazit Z Theranostics; 2019; 9(25):7506-7524. PubMed ID: 31695783 [No Abstract] [Full Text] [Related]
16. [EXPRESSIONS OF TRANSFORMING GROWTH FACTOR β1 AND CONNECTIVE TISSUE GROWTH FACTOR IN HUMAN LUMBAR INTERVERTEBRAL DISCS IN DIFFERENT DEGREES OF DEGENERATION]. Li N; Xiu L; Guan T; Hu Z; Jin Q Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jul; 28(7):891-5. PubMed ID: 26462357 [TBL] [Abstract][Full Text] [Related]
17. The Notochord, Notochordal cell and CTGF/CCN-2: ongoing activity from development through maturation. Erwin WM J Cell Commun Signal; 2008 Dec; 2(3-4):59-65. PubMed ID: 19003520 [TBL] [Abstract][Full Text] [Related]
18. Dedifferentiation-like reprogramming of degenerative nucleus pulposus cells into notochordal-like cells by defined factors. Zhang Y; Liang C; Xu H; Li Y; Xia K; Wang L; Huang X; Chen J; Shu J; Cheng F; Shi K; Wang J; Tao Y; Wang S; Zhang Y; Li H; Feng S; Li F; Zhou X; Chen Q Mol Ther; 2024 Aug; 32(8):2563-2583. PubMed ID: 38879755 [TBL] [Abstract][Full Text] [Related]
19. The research of transgenic human nucleus pulposus cell transplantation in the treatment of lumbar disc degeneration. Wang HC; Jin CH; Kong J; Yu T; Guo JW; Hu YG; Liu Y Kaohsiung J Med Sci; 2019 Aug; 35(8):486-492. PubMed ID: 31091017 [TBL] [Abstract][Full Text] [Related]
20. Notochordal and nucleus pulposus marker expression is maintained by sub-populations of adult human nucleus pulposus cells through aging and degeneration. Richardson SM; Ludwinski FE; Gnanalingham KK; Atkinson RA; Freemont AJ; Hoyland JA Sci Rep; 2017 May; 7(1):1501. PubMed ID: 28473691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]